Cancer trials

CRISTAL-APC is a clinical trial led by Cambridge University Hospitals and the University of Cambridge. This trial aims to study whether VP-002…

Four in 10 women diagnosed with breast cancer undergo mastectomy with or without breast reconstruction and less than half are satisfied with how they look unclothed. Breast conservation (removing the area with the lump only) can offer less…

Neutropenia is a common side effect of chemotherapy and is characterised by low levels of neutrophils, which are a type of white blood cell. This increases the likelihood of a patient further developing neutropenic sepsis, a life-threatening…

Breast cancer is the most common cancer in women worldwide, and the second most common cancer overall, with more than 1,676,000 people newly diagnosed in 2012 (25% of all female cancer cases and 12% of the total). Although advances in screening,…

The effects of brain tumours on the normal brain function make them different to other cancers. They frequently affect characteristics and…

Germ cell tumours of the testis are the most common malignancy affecting adolescent and young adult males in Australia and many other Western countries, with a disproportionally high amount of healthy life lost each year due to the early age at…

Renal cell cancer (RCC) is the 7th commonest cancer in the UK (12,500 new cases/year) and the most lethal of the urological malignancies with a 50% 10-year survival when considering all patients. Vascular endothelial growth factor (VEGF) tyrosine…